Bright Minds Biosciences
DRUG
#7527
Rank
A$0.71 B
Marketcap
A$72.76
Share price
-2.65%
Change (1 day)
-19.08%
Change (1 year)

Earnings for Bright Minds Biosciences (DRUG)

Earnings in 2026 (TTM): -A$41.25 Million

According to Bright Minds Biosciences's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$19.75 Million a decrease over its 2024 earnings that were of -A$2.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Bright Minds Biosciences from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$41.25 Million108.93%
2025 -A$19.75 Million607.9%
2024 -A$2.79 Million-61.3%
2023 -A$7.21 Million-46.9%
2022 -A$13.58 Million-7.52%
2021 -A$14.68 Million1162.13%
2020 -A$1.17 Million